Previously, it has been reported that CEACAM1 expression was obviously deregulated in BC and might serve as a diagnostic biomarker in BC30, 31, but until now there are no reports on the relationship between CEACAM1 and prognosis of patients with BC. Here, CEACAM1 is linked to breast cancer.